MedTrace Logo

Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study

NCT02917161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-08-09

No results posted yet for this study

Summary

MRI findings after successful PAE in patients suffering from BPH suggest a complete necrosis of the prostate after this intervention. Thus, PAE might also play a role in the treatment of prostate cancer.

This proof of concept study assess the impact of PAE in patients with proven prostate cancer.

Conditions

Interventions

DEVICE

Prostatic Artery Embolization (PAE)

PAE is performed 6 weeks before radical prostatectomy

Sponsors & Collaborators

  • Dominik Abt

    lead OTHER

Principal Investigators

  • Dominik Abt, MD · Cantonal Hospital St. Gallen

  • Livio Mordasini, MD · Cantonal Hospital Luzerne

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-06-30
Completion
2017-08-03

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02917161 on ClinicalTrials.gov